Should WEE(1) CHK(1) in on the FAM(122A)ily?
- 5 November 2020
- journal article
- editorial
- Published by Elsevier BV in Molecular Cell
- Vol. 80 (3), 377-378
- https://doi.org/10.1016/j.molcel.2020.10.011
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- CHK1 Inhibitor Blocks Phosphorylation of FAM122A and Promotes Replication StressMolecular Cell, 2020
- The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP InhibitionClinical Cancer Research, 2019
- Mechanisms of Oncogene-Induced Replication Stress: Jigsaw Falling into PlaceCancer Discovery, 2018
- CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or OlaparibCancer Research, 2017
- FAM122A, a new endogenous inhibitor of protein phosphatase 2AOncotarget, 2016
- Phase I Study of LY2606368, a Checkpoint Kinase 1 Inhibitor, in Patients With Advanced CancerJournal of Clinical Oncology, 2016
- Targeting the DNA Damage Response in CancerMolecular Cell, 2015
- LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent MechanismsMolecular Cancer Therapeutics, 2015
- Checkpoint kinase 1 in DNA damage response and cell cycle regulationCellular and Molecular Life Sciences, 2013
- Chk1 and Chk2 kinases in checkpoint control and cancerCancer Cell, 2003